Clinical Trial Update: COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on immune response in cancer patients undergoing SARS-CoV-2 mRNA vaccination; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Jules Bordet Institute | Conditions: Cancer | Phase 4 | Status: TERMINATED